The import of medicines under price control may be stuck for at least a month, as apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA), is unlikely to consider price revision

The editorial "Mr Mukherjee�s teaser" (March 24) should be an eye-opener for the government, both finance and health ministries. Otherwise, profit-making hospitals may further destroy health

National Pharmaceutical Pricing Authority (NPPA) has invoked the public interest clause in the Drugs Price Control Order to fix the price of an epileptic drug of Abbott Healthcare, the wholly owned

In a move that could bring more than half the country’s Rs 65,000-crore medicine market under price control, the health ministry plans to enlarge the scope and size of the National List of